These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


239 related items for PubMed ID: 17267457

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome.
    Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong AT, Cosgrave J, Sangiorgi GM, Airoldi F, Montorfano M, Michev I, Chieffo A, Carlino M, Corvaja N, Aoki J, Rodriguez Granillo GA, Valgimigli M, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW, Colombo A.
    J Am Coll Cardiol; 2006 May 16; 47(10):1949-58. PubMed ID: 16697310
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
    Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R.
    J Am Coll Cardiol; 2009 Sep 01; 54(10):894-902. PubMed ID: 19712798
    [Abstract] [Full Text] [Related]

  • 25. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
    Simonton CA, Brodie B, Cheek B, Krainin F, Metzger C, Hermiller J, Juk S, Duffy P, Humphrey A, Nussbaum M, Laurent S, STENT Group.
    J Am Coll Cardiol; 2007 Sep 25; 50(13):1214-22. PubMed ID: 17888837
    [Abstract] [Full Text] [Related]

  • 26. Treatment of non-left main bifurcation lesions using the sirolimus-eluting stent: A comparison of chronic outcomes of cross-over single stenting and crush stenting.
    Uchida Y, Wagatsuma K, Yamazaki J.
    J Cardiol; 2010 Mar 25; 55(2):180-8. PubMed ID: 20206070
    [Abstract] [Full Text] [Related]

  • 27. Sirolimus-eluting stent showed better one-year outcomes than paclitaxel-eluting stent in a real life setting of coronary intervention in Koreans.
    Suh JW, Park JS, Cho HJ, Kim MS, Kang HJ, Cho YS, Koo BK, Chung WY, Youn TJ, Chae IH, Choi DJ, Kim HS, Sohn DW, Oh BH, Park YB.
    Int J Cardiol; 2007 Apr 12; 117(1):31-6. PubMed ID: 17292498
    [Abstract] [Full Text] [Related]

  • 28. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK, Torguson R, Canos D, Rha SW, Chu WW, Clavijo L, Deible R, Gevorkian N, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.
    Am J Cardiol; 2005 Oct 15; 96(8):1100-6. PubMed ID: 16214445
    [Abstract] [Full Text] [Related]

  • 29. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.
    Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melián F, Herrador J, Ureña I, Burgos L.
    Am Heart J; 2004 Nov 15; 148(5):857-64. PubMed ID: 15523318
    [Abstract] [Full Text] [Related]

  • 30. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice.
    Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Agostoni P, Babic R, Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M, Colombo A.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2320-8. PubMed ID: 17572247
    [Abstract] [Full Text] [Related]

  • 31. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH, Dangas GD, Solinas E, Aoki J, Parise H, Kimura M, Franklin-Bond T, Dasgupta NK, Kirtane AJ, Moussa I, Lansky AJ, Collins M, Stone GW, Leon MB, Moses JW, Mehran R.
    Am J Cardiol; 2008 Mar 15; 101(6):801-6. PubMed ID: 18328844
    [Abstract] [Full Text] [Related]

  • 32. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, Ussia GP, Tamburino C.
    Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):976-83. PubMed ID: 17295334
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions.
    Li JJ, Qin XW, Yang XC, Li ZC, Zeng HS, Xu B, Gao Z, Wu YJ, Zhang X, Zhang CY.
    Clin Chim Acta; 2008 Oct 01; 396(1-2):38-42. PubMed ID: 18634770
    [Abstract] [Full Text] [Related]

  • 35. Sirolimus-eluting cobalt-chromium stents: two-year clinical results from first-in-man study on the Firebird 2 stent.
    Xu B, Zhang Q, Yang YJ, Qiao SB, Zhang RY, Zhang JS, Hu J, Qin XW, Hong T, Li JP, Chen JL, Huo Y, Gao RL, Shen WF.
    Chin Med J (Engl); 2008 Mar 20; 121(6):492-7. PubMed ID: 18364131
    [Abstract] [Full Text] [Related]

  • 36. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
    Byrne RA, Mehilli J, Iijima R, Schulz S, Pache J, Seyfarth M, Schömig A, Kastrati A.
    Eur Heart J; 2009 Apr 20; 30(8):923-31. PubMed ID: 19240066
    [Abstract] [Full Text] [Related]

  • 37. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group.
    Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Real-world outcome of coronary bifurcation lesions in the drug-eluting stent era: results from the 4,314-patient Italian Society of Invasive Cardiology (SICI-GISE) Italian Multicenter Registry on Bifurcations (I-BIGIS).
    Romagnoli E, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio S, Loi B, Lioy E, Benassi A, Patti A, Gaspardone A, Capodanno D, Biondi-Zoccai GG, Sangiorgi G, I-BIGIS Study Group Milan, Italy.
    Am Heart J; 2010 Sep 15; 160(3):535-542.e1. PubMed ID: 20826264
    [Abstract] [Full Text] [Related]

  • 40. Ostial and midshaft lesions vs. bifurcation lesions in 1111 patients with unprotected left main coronary artery stenosis treated with drug-eluting stents: results of the survey from the Italian Society of Invasive Cardiology.
    Palmerini T, Sangiorgi D, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Ruffini M, Bartorelli AL, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Bolognese L, Benassi A, Palmieri C, Filippone V, Barlocco F, Lauria G, De Servi S.
    Eur Heart J; 2009 Sep 15; 30(17):2087-94. PubMed ID: 19508996
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.